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Background
Whether elective endovascular repair of abdominal aortic aneurysm reduces long-term morbidity and mortality, as compared with traditional open repair, remains uncertain.
Methods
We randomly assigned 881 patients with asymptomatic abdominal aortic aneurysms who were candidates for both procedures to either endovascular repair (444) or open repair (437) and followed them for up to 9 years (mean, 5.2). Patients were selected from 42 Veterans Affairs medical centers and were 49 years of age or older at the time of registration.
Results
More than 95% of the patients underwent the assigned repair. For the primary outcome of all-cause mortality, 146 deaths occurred in each group (hazard ratio with endovascular repair versus open repair, 0.97; 95% confidence interval [CI] , 0.77 to 1.22; P = 0.81). The previously reported reduction in perioperative mortality with endovascular repair was sustained at 2 years (hazard ratio, 0.63; 95% CI, 0.40 to 0.98; P = 0.04) and at 3 years (hazard ratio, 0.72; 95% CI, 0.51 to 1.00; P = 0.05) but not thereafter. There were 10 aneurysm-related deaths in the endovascular-repair group (2.3%) versus 16 in the open-repair group (3.7%) (P = 0.22). Six aneurysm ruptures were confirmed in the endovascular-repair group versus none in the open-repair group (P = 0.03). A significant interaction was observed between age and type of treatment (P = 0.006); survival was increased among patients under 70 years of age in the endovascular-repair group but tended to be better among those 70 years of age or older in the open-repair group.
Conclusions
Endovascular repair and open repair resulted in similar long-term survival. The perioperative survival advantage with endovascular repair was sustained for several years, but rupture after repair remained a concern. Endovascular repair led to increased long-term survival among younger patients but not among older patients, for whom a greater benefit from the endovascular approach had been expected. (Funded by the Department of Veterans Affairs Office of Research and Development; OVER ClinicalTrials.gov number, NCT00094575.) ach year, 40,000 patients in the United States undergo elective procedures to repair abdominal aortic aneurysms. 1 These procedures result in about 1250 perioperative deaths -more than for any other general or vascular surgical procedure, with the exception of colectomy. 2 Endovascular repair was introduced in the 1990s as a less invasive method than traditional open repair. Randomized trials have shown that endovascular repair reduces perioperative mortality, [3] [4] [5] but in the United Kingdom Endovascular Aneurysm Repair 1 (EVAR 1) trial 3 and the Dutch Randomized Endovascular Aneurysm Management (DREAM) trial, 4 this advantage was lost within 2 years owing to excess late deaths in the endovascular-repair groups. In the Open versus Endovascular Repair (OVER) Veterans Affairs Cooperative Study, excess late deaths were not observed in the endovascular-repair group at 2 years. 5 We report here the long-term results of that study.
Me thods
Study Design and Oversight
The study design and methods have been described previously 5 and are briefly reviewed here. The study was designed, conducted, analyzed, and written by the authors, who also wrote the first draft and vouch for the data and analysis. The study was approved by a central human rights committee and the institutional review board at each participating center. An independent data and safety monitoring committee reviewed the data at regular intervals. The study was conducted in accordance with the protocol, available with the full text of this article at NEJM.org. The authors vouch for the accuracy and completeness of the data and analysis.
Patients
Patients with abdominal aortic aneurysms for which repair was planned were eligible for the study if the aneurysm had a maximum external diameter of at least 5.0 cm, an associated iliacartery aneurysm with a maximum diameter of at least 3.0 cm, or a maximum diameter of at least 4.5 cm plus either rapid enlargement (an increase of at least 0.7 cm in 6 months or 1.0 cm in 12 months) or a saccular appearance. Patients were excluded if they were not considered to be a candidate for either procedure, had previously undergone abdominal aortic surgery, needed urgent repair, or were unable or unwilling to give informed consent or to follow the protocol.
Procedures
Patients were randomly assigned to open repair or endovascular repair with equal probability. Only endovascular-repair devices approved by the Food and Drug Administration were used in the study. The specific type of endovascular-repair devices intended for a particular patient, in the event that the patient was assigned to endovascular repair, was reported to the coordinating center before randomization to permit subgroup comparisons. Though group assignments were of necessity unblinded, concealment of treatment assignments from site investigators and patients was maintained throughout randomization by means of telephone calls to the coordinating center, as described previously. 5 The protocol required that a study-approved vascular surgeon or interventional radiologist perform the aneurysm repair within 6 weeks after randomization.
Follow-up visits were scheduled at 1 month after aneurysm repair, at 6 and 12 months after enrollment, and then yearly. All follow-up visits after endovascular repair included computed tomography (CT) and plain radiography of the abdomen, whereas after open repair, CT alone was required at 1 year and at the end of the study. Patients were contacted by telephone monthly during the first 14 months after the repair and then annually midway between study visits to identify interim outcomes, and they were asked to maintain a log of all health care visits. Additional follow-up information was obtained by the coordinating center with the use of national data sets.
Outcomes
The primary outcome was long-term mortality from any cause. Short-term secondary outcomes have been reported previously. 5 Long-term secondary outcomes included prespecified subgroups of the primary outcome; secondary therapeutic procedures that resulted directly or indirectly from the initial procedure and that required a separate trip to the procedure suite (with each trip to the procedure suite counting as one secondary procedure), including any unplanned surgical procedures within 30 days after the initial procedure and any additional aortoiliac procedures at any time; post-repair hospitalizations; uncorrected aortoiliac abnormalities noted on imaging at the end of the study; and health-related quality-of-life factors, including erectile function.
Cause of death and secondary therapeutic procedures were adjudicated by an outcomes commit-tee whose members were unaware of the group assignments. Aneurysm-related mortality was not a prespecified outcome because of the potential for ascertainment bias, but it is reported here for comparison with other trials. All deaths that occurred within 30 days after the repair or during the hospitalization for repair were considered to be related to the aneurysm, as were all late deaths adjudicated as having resulted directly or indirectly from the aneurysm or its treatment.
Health-related quality of life was assessed with the use of two brief questionnaires: the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) and the European Quality of Life-5
Dimensions (EQ-5D) instrument, which were completed at baseline and at follow-up visits. The SF-36 evaluates eight dimensions of health aggregated into two summary measures: a mental component score and a physical component score. 6 We also calculated the physical component score with deaths included. 7 The EQ-5D consists of a five-item questionnaire used to generate an index score, with U.S. population-based preference weights, and a visual-analogue scale. 8 Erectile function was assessed with the use of the previously validated International Index of Erectile Function (IIEF). 9 Questionnaires were completed by the patients and reviewed for completeness by study personnel. 
Statistical Analysis
The study began in October 2002 and was reconfigured in 2005, as previously described. 5 For the revised plan, which included 5 years of enrollment plus 4 years of follow-up, we calculated that a sample of 872 patients would provide 80% power to detect a 25% relative reduction in mortality at a two-sided alpha level of 0.05. To reach this number, enrollment was continued for an additional 6 months, until April 2008, at three centers.
Data were analyzed according to the intentionto-treat principle. Estimates of cumulative event rates were calculated by means of the KaplanMeier method, and hazard ratios with confidence intervals were estimated by means of Cox proportional-hazards models. 10 The effect of treatment in prespecified subgroups was assessed by means of treatment-subgroup interactions in the Cox models. Variables were compared with the use of chi-square tests and t-tests. P values of less for all between-group comparisons of baseline characteristics except aspirin use (P = 0.01). ACE denotes angiotensinconverting enzyme. † Race was self-reported. ‡ The body-mass index is the weight in kilograms divided by the square of the height in meters. § "Ever smoked" was defined as having smoked more than 100 cigarettes over the person's lifetime. ¶ The glomerular filtration rate (GFR) was estimated with the use of the four-variable equation in the Modification of Diet in Renal Disease study.
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‖ For a description of the RAND criteria for surgical risk, in which higher scores denote higher risk, 5 see Table S1 in the Supplementary Appendix. than 0.05 were considered to indicate statistical significance; two-sided P values are reported. Statistical analyses were performed with the use of SAS software, version 9.1 (SAS Institute). Restricted mean survival (analogous to the area under the curve for a survival plot) was assessed with the use of the pseudo-mean values approach. 11 Longitudinal mixed-effects models, adjusted for baseline values, were used to compare the two groups with respect to quality-of-life measures. Treatment effect and change in quality-of-life measures over time were assessed in repeatedmeasures models (with unstructured covariance), with the assigned repair method and baseline measurements used as covariates.
R e sult s
Patients
A total of 881 patients at 42 Veterans Affairs medical centers were randomly assigned to either endovascular repair (444) or open repair (437) and were followed for up to 9 years (mean, 5.2). Details of exclusions before randomization were described previously 5 and are shown in Figure S1 in the Supplementary Appendix, available at NEJM.org. Characteristics at the time of randomization were also described previously 5 and are shown in Table 1 . The two groups of patients were similar, with no significant differences except that a greater proportion of the open-repair group used aspirin. The mean age of the study cohort was 70 years, and 99% of the patients were men; the mean maximum diameter of the abdominal aortic aneurysm was 5.7 cm. A total of 96% of the randomly assigned patients underwent the assigned repair; in another 2%, the assigned repair was attempted but not completed (Fig. S1 in the Supplementary Appendix).
At the end of the study, on October 15, 2011, there were 4578 patient-years of follow-up, and vital status was confirmed for all patients. Of patients alive at the end of the study, 93% had attended the study clinic during the final year, and telephone calls and databases were used to obtain follow-up data regarding secondary outcomes in another 6%. Throughout the study, the proportion of quality-of-life forms completed ranged from 85% of those possible for the EQ-5D (an indicator of the rate of study-visit attendance) to 67% for the IIEF (which some patients declined to complete, especially after previously noting erectile dysfunction). Table 2 ). As reported previously, perioperative mortality (death during hospitalization or within 30 days after the procedure) was lower in the endovascular-repair group than in the openrepair group (0.5% vs. 3.0%, P = 0.004). In our earlier analysis, with 2-year results available for 80% of patients, the difference in mortality between the two groups was no longer significant at 2 years. In the current analysis, which includes all patients, the difference in mortality was significant at 2 years (hazard ratio with endovascular repair, 0.63; 95% CI, 0.40 to 0.98; P = 0.04) and was of borderline significance at 3 years (hazard ratio, 0.72; 95% CI, 0.51 to 1.00; P = 0.05) but not thereafter. The restricted mean survival was also not significantly different between the two groups at 5 years (P = 0.13) and at 9 years (P = 0.65).
Ten deaths (2 perioperative and 8 late) were determined to be aneurysm-related in the endovascular-repair group (2.3%), as compared with 16 deaths (13 perioperative and 3 late) in the openrepair group (3.7%; absolute difference, −1.4 percentage points; 95% CI, −3.7 to 0.8; P = 0.22). Six aneurysm ruptures were confirmed in the endovascular-repair group (4 occurred more than 5 years after the repair, and 3 of the 6 were fatal), as compared with no ruptures in the open-repair group (P = 0.03). Of the six patients with rupture, one had declined aneurysm repair after randomization, another had missed appointments for follow-up imaging studies for 3 years before the rupture, and a third patient declined treatment after graft migration and sac enlargement were diagnosed. One of the remaining three patients had undergone recent endovascular treatment of a proximal aortic dissection, and in the other two patients, large type 1 endoleaks were diagnosed at the time of rupture.
Secondary Therapeutic Procedures and other Outcomes
A total of 148 secondary therapeutic procedures were performed in 98 patients in the endovascularrepair group and 105 procedures were performed in 78 patients in the open-repair group (P = 0.26 for the number of procedures and P = 0.12 for the number of patients) ( (Fig. 1B) was similar in the two groups throughout the study (hazard ratio for a secondary procedure or death with endovascular repair, 1.06; 95% CI, 0.87 to 1.28; P = 0.57).
Several aortoiliac abnormalities remained untreated at the end of the study. Of the 298 patients in the endovascular group who were alive at the end of the study, 244 underwent CT within the preceding year; 3 of these patients were found to have an enlarged aneurysm sac, and 1 patient each had a kinked graft, graft migration, and an iliacartery aneurysm greater than 3 cm in diameter. Of the 291 patients in the open-repair group who were alive at the end of the study, 195 underwent CT within the preceding year, which revealed iliac-artery dissection in 1 patient, an iliac-artery aneurysm greater than 3 cm in diameter in 2 patients, and a proximal abdominal aortic aneurysm greater than 4 cm in diameter in 1 patient.
The number of hospitalizations after the initial aneurysm repair was similar in the two groups (Table 2 ). More hospitalizations were determined to be aneurysm-related in the endovascular-repair group than in the open-repair group, but the difference was not significant.
Long-term mortality for prespecified subgroups of patients is shown in Figure 2 . Survival was better with endovascular repair than with open repair among patients younger than 70 years of age (hazard ratio, 0.65; 95% CI, 0.43 to 0.98; P = 0.04). Among those 70 years of age or older, survival was better with open repair than with endovascular repair, but this effect was of marginal significance (hazard ratio, 1.31; 95% CI, 0.99 to 1.73; P = 0.06), with the result that the interaction between treatment group and age group was highly significant (P = 0.006). In a post hoc analysis to further evaluate these findings, we examined survival plots and cause of death according to age group (Fig. S2a and S2b and Table S2 in the Supplementary Appendix). The between-group difference in mortality among the younger patients may be related to a difference in cancer-related deaths (Table S2 in the endovascular-repair group tending to fare relatively better in later years (P = 0.054). Survival after endovascular repair, as compared with open repair, tended to be worse when Medtronic AneuRx was the intended graft (P = 0.06 for the interaction between treatment group and use of AneuRx vs. another device). This device had been used in 6 of the 10 patients with aneurysmrelated deaths in the endovascular-repair group and in 2 of the 3 patients with nonfatal ruptures.
As shown in Figure 3 , there were no significant differences between the two treatment groups in terms of health-related quality of life or erectile function.
Discussion
In this long-term, multicenter, randomized trial involving patients with abdominal aortic aneurysm, there was no significant difference in the primary outcome of long-term all-cause mortality between the endovascular-repair group and the open-repair group. The perioperative survival advantage with endovascular repair was sustained for several years, after which there was no significant difference between the two groups. Endovascular repair led to improved long-term survival among patients younger than 70 years of age, but among older patients it tended to reduce survival.
Aneurysm rupture after repair was uncommon but occurred only in the endovascular-repair group, resulting in a significant between-group difference. We found no significant difference between the two groups with respect to number of secondary therapeutic procedures, number of postrepair hospitalizations, quality of life, or erectile dysfunction.
Much of the early enthusiasm for endovascular repair focused on the expected advantage among old or infirm patients who were not good candidates for open repair. Our finding that endovascular repair resulted in better outcomes among younger patients and in worse outcomes among older patients was therefore surprising. The EVAR 1 study showed no interaction between age and treatment effect, though the data, as presented, did not allow an assessment of trends. 3 However, the EVAR 1 study also showed that the short-term benefit of endovascular repair was most pronounced among the patients who were most fit, 13 and long-term complications and reinterventions after endovascular repair were more common among older patients. 14 The clinical implications of this age effect must be reconciled with our finding that late rupture occurred only in the endovascular-repair group. The procedure associated with late failures would seem to be less desirable for use in younger patients. The late-rupture rate in our study was low, however, with only 6 ruptures during 4576 patient-years of follow-up, which is less than one third the rate in the EVAR 1 study (25 ruptures, also all after endovascular repair, during 5309 patient-years of follow-up). 3 Furthermore, 4 of the 6 ruptures in our study, including 2 of 3 fatal ruptures, occurred in patients older than 70 years of age at study entry. Three of the 6 ruptures in our study occurred in patients who did not adhere to the recommended follow-up and endovascular procedures. Pending longer-term data, we therefore consider endovascular repair to be a reasonable option in patients younger than 70 years of age who are likely to adhere to medical advice.
We found that the rates of secondary therapeutic procedures were similar after endovascular repair and open repair, whereas in the EVAR 1 study, the rate of secondary procedures was much higher after endovascular repair. 3 However, in that study, "readmission data were not collected for abdominal hernias or other complications related to open repair," thus rendering the comparison unbalanced. As noted in our earlier report, repair of incisional hernia was the most common secondary therapeutic procedure after open repair, which was also the case in the DREAM trial. 4 In that trial, reinterventions began to differ significantly in favor of open repair after 4 years, whereas in our study, the two groups remained similar throughout the study in terms of the incidence of death or secondary therapeutic procedures.
The excess late deaths that resulted in loss of the perioperative survival advantage in the endovascular-repair group occurred later in our study than in the EVAR 1 and DREAM trials, but they occurred nevertheless. Although this convergence of survival curves could be attributed to chance, its occurrence in all three studies argues otherwise. The EVAR 1 investigators attributed loss of the perioperative survival advantage in their study to late ruptures after endovascular repair. 3 In our study, there were only three fatal aneurysm ruptures, rendering this explanation inadequate. Furthermore, if loss of the perioperative survival advantage were due to late deaths attributable to endovascular repair, one would expect the survival curves to eventually cross and the endovascularrepair group to have worse long-term survival, but there is no evidence for this in any of the three studies. Another proposed explanation for the convergence of survival curves, 15 and perhaps the most likely one, is that the perioperative deaths after open repair tended to be among the patients who were the most frail, with the curves converging as deaths occurred in these frail patients in the endovascular-repair group.
Our results suggest that endovascular repair continues to improve and is now an acceptable alternative to open repair even when judged in terms of long-term survival. However, our results also indicate that late rupture remains a concern and that endovascular repair does not yet offer a long-term advantage over open repair, particularly among older patients, for whom such an advantage was originally expected.
